Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, LIC

HealthMark Group and Credo Health Partner to End Chart Chasing with a Comprehensive Digital Medical Record Solution


New end-to-end solution will ease the administrative burden of medical record management

LOS ANGELES, Feb. 27, 2024 /PRNewswire-PRWeb/ -- HealthMark Group and Credo Health today announced a strategic partnership to deliver medical records to patients, providers and other key stakeholders through a comprehensive, end-to-end digital medical record management solution at the ViVE 2024 Conference in Los Angeles.

This new solution will leverage HealthMark's digital platform, Request Managertm to efficiently manage all inbound requests for medical records and significantly reduce the administrative burden traditionally placed on providers. Credo's PreDx platform will retrieve patient medical histories and employ an AI-driven summary to equip providers with a concise, relevant clinical history before each patient's visit.

"By leveraging Credo Health's innovative record retrieval technology with our digital release of information platform, we are setting a new standard for sharing important clinical data with patients, providers and other requestors," said Bart Howe, HealthMark CEO. "Providers can now enjoy a hassle-free experience, focusing on patient care rather than tedious administrative tasks."

In the United States, the practice of chasing charts places a significant drain on provider resources. This new solution offers a seamless and efficient alternative to chart chasing and communicating through fax for healthcare providers, addressing the need for a streamlined, digital solution that covers both medical record retrieval and release.

"Joining forces with HealthMark represents a pivotal step forward in modernizing medical record retrieval management," said Carm Huntress, Credo founder and CEO. "Our combined solution not only streamlines but also completely revolutionizes how providers interact with medical records, eliminating the need for traditional and time-consuming processes like phone and faxing."

###

About HealthMark Group: HealthMark Group is a leading provider of digital health information management solutions for healthcare providers across the country. With an unrelenting focus on the patient experience, HealthMark delivers secure, compliant, and technology-driven solutions to streamline the patient information journey. Our release of information solution helps thousands of hospitals and clinics transform administrative processes into seamless digital encounters. HealthMark Group is based in Dallas, TX and has been named to both the Dallas 100 and the Inc. 5000 for multiple years in a row as one of the fastest growing companies in the region and across the country. To learn more, visit us at healthmark-group.com or follow us on LinkedIn.

About Credo Health: Credo Health's PreDx product offers a pre-encounter risk analysis, clinical summaries and HEDIS Gap Closure through an AI-enabled analysis of digital medical records, allowing healthcare providers to make more informed clinical decisions and deliver more personalized care. Through its innovative solutions, Credo is transforming healthcare, facilitating better decision-making, and driving meaningful progress in the industry. For more information, visit credohealth.com.

By leveraging Credo Health's innovative record retrieval technology with our digital release of information platform, we are setting a new standard for sharing important clinical data with patients, providers and other requestors.

Media Contact

Ann Baty, HealthMark Group, 1 469-607-0950, [email protected], https://healthmark-group.com/

Matt Bloodgood, Credo Health, 1 720-352-2276, [email protected], https://www.credohealth.com/ 

LinkedIn

SOURCE HealthMark Group


These press releases may also interest you

at 06:00
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that Adrian Haigh has departed from his position as Fennec's Chief Operating Officer as of June 30, 2024. After nine years as an independent director,...

at 06:00
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") , a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a mid-year corporate update to discuss recent positive developments in the NurOwn® program on...

at 05:26
Pope Francis hosted distinguished scientists and experts from various countries and disciplines at a private audience at the Apostolic Palace in Vatican City. The selected attendees were participants in the Three-day International Conference on...

at 05:05
LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced the appointment of Staph Leavenworth Bakali as independent Chairman of its Board of Directors. Mr....

at 04:30
1 in 2 adults in the US have high blood pressure, and if you're over 55, the odds jump to 4 in 5. Given that heart attacks are the No.1 killer of men and women around the world, often precipitated by high blood...



News published on and distributed by: